CHARLES J CASAMENTO
CIK 1117167 · last filed 2026-01-14
CHARLES J CASAMENTO is a corporate insider who has filed 143 SEC Form 4 insider transactions across 10 companies since 2007. The most recent filing, for ETON, was dated Jan 14, 2026. Across all open-market trades the lifetime net is −$3.4M, making them a net seller over the disclosed history. Current disclosed insider exposure totals $13.1M across reported positions.
"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.
$13.07M
10
143
-$3.43M
Holdings By Company
| Symbol | Role | Shares | Price | Disclosed Exposure | Lifetime OM Net | Filings | Latest Filed |
|---|---|---|---|---|---|---|---|
| ETON | Director | 71,920 | $46.65 | $3.36M | $51.4K | 10 | 2026-01-14 |
| RLMD | Director | 21,484 | $5.20 | $111.7K | -$2.11M | 32 | 2025-12-16 |
| GTBP | Director | — | $0.31 | — | $0 | 2 | 2025-09-08 |
| PaxMedica, Inc. (PXMD) Delisted | Director | 2,386 | $0.00 | $1 | $0 | 5 | 2024-03-14 |
| GridAI Technologies Corp. (FWBI) Delisted | Director | 19,937 | $2.96 | $59.0K | -$1.8K | 5 | 2024-01-04 |
| GridAI Technologies Corp. (AZRX) Delisted | Director | 224,996 | $3.45 | $776.2K | $12.7K | 15 | 2021-01-06 |
| ASTX | Director | 0 | $9.83 | $0 | -$476.8K | 10 | 2013-06-17 |
| VIVUS INC (VVUS) Delisted | Director | 2,612 | — | — | -$910.3K | 15 | 2013-04-22 |
| Astex Pharmaceuticals, Inc (SUPG) Delisted | Director | — | — | — | $0 | 6 | 2011-06-16 |
| COR | Director | 30,000 | $320.02 | $9.60M | $7.5K | 5 | 2009-08-24 |
Recent Filings
143 filings| Filed | Symbol | Action | Net Shares | Net $ | Link |
|---|---|---|---|---|---|
| 2026-01-14 | ETON | Grant (A) | — | $0 | EDGAR |
| 2025-12-16 | RLMD | Grant (A) | — | $0 | EDGAR |
| 2025-09-08 | GTBP | Grant (A) | — | $0 | EDGAR |
| 2025-06-30 | RLMD | Grant (A) | — | $0 | EDGAR |
| 2025-01-06 | ETON | Grant (A) | — | $0 | EDGAR |
| 2024-10-23 | RLMD | Gift (G) | −13,000 | $0 | EDGAR |
| 2024-09-11 | RLMD | Buy (P) | +13,000 | $33.3K | EDGAR |
| 2024-05-29 | RLMD | Mixed | — | $0 | EDGAR |
| 2024-03-14 | PaxMedica, Inc. (PXMD) Delisted | Tax (F) | −992 | -$684 | EDGAR |
| 2024-02-15 | ETON | Grant (A) | — | $0 | EDGAR |
Notice (144 / 144/A): Form 144 is a notice of intent to sell restricted/control stock under Rule 144, filed before the sale; 144/A is an amendment. Many notices are pre-scheduled under Rule 10b5-1 plans. A Form 4 with code S typically follows within a few days when the planned sale executes; missing follow-up Form 4s suggest the notice was cancelled or modified.